Brief: Respira Therapeutics Says Enters Into Agreement Granting Gossamer Option To Acquire Co From Samsara Biocapital
25/09/2025 13:25
Sept 25 (Reuters) - Gossamer Bio GOSS.O: RESPIRA THERAPEUTICS ENTERS INTO AGREEMENT WITH GOSSAMER BIO (GOSSAMER) GRANTING GOSSAMER OPTION TO ACQUIRE RESPIRA FROM SAMSARA BIOCAPITAL Source text: ID:nPn7Lyk3Pa Further company coverage: GOSS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gossamer Bio
See all newsBrief: Gossamer Bio Submits New Drug Application To US FDA For Seralutinib For The Treatment Of Pulmonary Arterial Hypertension
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Gossamer Bio - Board Approves Amendment And Restatement Of Bylaws Effective Sept 3, 2026 - SEC Filing